Biocept Microfluidic Technology Wins USPTO Patent
The US patent 7,695,956, entitled ‘Device for Cell Separation and Analysis and Method of Using,’ protects Biocept’s microflow device to isolate cells from a bodily fluid using a
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.